NEWS

We Work For Health Executive Director Dan Leonard issued the following statement in response to the United States Trade Representative’s Section 301 investigation into Germany's pharmaceutical pricing policies. “The USTR’s Section 301 investigation underscores the growing impact of Germany’s harmful pharmaceutical pricing policies on American patients, workers, and innovators. By keeping prices artificially below market value, Germany and other countries shift the bulk of t

We Work For Health issued the following statement ahead of an anticipated vote to repeal the ORPHAN Cures Act in the budget reconciliation bill. "As the Senate prepares to vote on a series of amendments to the reconciliation bill, we urge lawmakers to reject the Welch amendment, which would repeal the ORPHAN Cures Act — a critical fix to the Inflation Reduction Act that was signed into law last year." "For the nearly 30 million Americans living with rare diseases, the ORPHAN

We Work For Health Executive Director Dan Leonard issued the following statement ahead of an anticipated vote “As Congress once again prepares for a long evening of budget reconciliation debates, we urge lawmakers to reject proposals – such as most favored nation (MFN) – that would undermine America’s world leadership in healthcare innovation and industry. MFN and similar government price control mandates would not lower patients’ out-of-pocket expenses, nor would they addres

Ahead of World Intellectual Property (IP) Day on April 26, We Work For Health Executive Director Dan Leonard issued the following statement: “World Intellectual Property Day is a reminder that medical innovation is the result of deliberate policy choices. In health care, intellectual property determines whether bold ideas are pursued, whether long‑term research is sustained and whether discoveries ultimately reach patients as treatments, diagnostics or cures. The United State

We Work For Health Executive Director Dan Leonard issued the following statement in response to President Trump’s call for the codification of Most Favored Nation price controls during his State of the Union Address. “Last night, we heard again from the Administration about their plans to lower healthcare costs for American families – an admirable goal that has remained a priority for President Trump. We Work For Health shares the Administration's urgent desire to address t

We Work For Health Executive Director Dan Leonard issued the following statement in response to the Center for Medicare & Medicaid Services’ (CMS) announcement of the next selection of drugs in Medicare to be negotiated under the Inflation Reduction Act (IRA): “As the Administration continues to add drugs to this list, it reinforces a troubling path driven by misguided and flawed efforts to advance government price controls under the Inflation Reduction Act. This trend is f

We appreciate the administration's continued focus on making healthcare more affordable for American families. The rising cost is a genuine concern, and policymakers are right to demand accountability from those responsible. That's why we commend the administration's and Congress’ efforts to hold healthcare middlemen, including corporate insurers and their subsidiaries, accountable for their anti-competitive practices and opacity that drive up costs throughout the entire syst

WASHINGTON, D.C. (Dec. 29, 2025) – We Work For Health commends the Trump administration for recognizing the substantial role corporate insurers and their integrated subsidiaries play in driving up costs and restricting access to care for American families. The administration's announcement of their intent to bring healthcare insurance executives to the table and examine the full scope of insurance industry practices represents the most necessary and critical step toward meani

WASHINGTON, D.C. (Dec. 19, 2025) We Work For Health released the following statement today in response to the Centers for Medicare & Medicaid Services announcing the Global Benchmark for Efficient Drug Pricing (GLOBE) and Guarding U.S. Medicare Against Rising Drug Costs (GUARD) models: “Applying the most favored nation (MFN) pricing models to Medicare Parts B and D – including sweeping Medicare demonstrations that would mandate price controls across broad categories of Part

November 26, 2025 (Washington, DC) We Work For Health Executive Director Dan Leonard issued the following statement in response to the administration’s announcement on the Maximum Fair Prices (MFP) for IPAY 2027 selected drugs: “We Work For Health has been sounding the alarm about the dangers of government price controls since the passage of the Inflation Reduction Act (IRA). This latest announcement from the Administration is yet another troubling consequence of that pol

WASHINGTON, D.C. (May 12, 2025) — We Work For Health released the following statement in response to the executive order signed Monday...

WASHINGTON, D.C. (May 5, 2025) — We Work For Health released the following statement in response to reports around foreign reference...